INNOVACAPNSEINNOVA CAPTAB LIMITEDMinimalNeutral
Announced Fri, 2 Oct, 2026 · 19:33 IST

AGM 2026 voting results: All 10 resolutions passed, board and KMPs re-appointed

INNOVACAP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.9%Reaction day
₹1153.00
prior close
₹1168.50
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.0%-0.9% vs market
Pharmaceuticals peers, median of 173sector-0.7%-0.2% vs sector

On the reaction day the stock moved 0.9 pts less than Nifty Microcap 250 and 0.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.1
10m
-0.4
15m
-0.8
30m
-0.8
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.9+0.0-0.9-0.7-0.2
Next day
-1.7+1.3-3.1+0.6-2.3
2d
+1.4+1.1+0.3+0.3+1.1
3d
-2.3-1.7-0.5-2.3+0.0
4d
-3.1-1.4-1.6-2.1-1.0
5d
-6.7-0.6-6.1-2.5-4.2
1w
-8.6+0.3-8.9-2.4-6.1
15d
-7.3pendingpending-4.3-3.0
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Innova Captab held its 22nd AGM on Sept 30, 2026 via video conferencing. All 10 resolutions passed with about 90.2% voting participation. Key items adopted: FY26 audited financials, re-appointment of statutory auditors B S R and Co LLP for 5 years (FY27 to FY31), re-appointment of Chairman Manoj Lohariwala and MD Vinay Lohariwala for 5 years each at Rs 2.5 crore per annum, and re-appointment of 4 independent directors. Bassi re-appointment saw the highest dissent at about 10%.

Likely market impact

Routine AGM approvals with strong shareholder support. Leadership and auditor continuity confirmed. Mild dissent on one independent director re-appointment.